STOPP/START criteria for potentially inappropriate prescribing in older people: version 3
- PMID: 37256475
- PMCID: PMC10447584
- DOI: 10.1007/s41999-023-00777-y
STOPP/START criteria for potentially inappropriate prescribing in older people: version 3
Erratum in
-
Correction: STOPP/START criteria for potentially inappropriate prescribing in older people: version 3.Eur Geriatr Med. 2023 Aug;14(4):633. doi: 10.1007/s41999-023-00812-y. Eur Geriatr Med. 2023. PMID: 37326916 Free PMC article. No abstract available.
Abstract
Purpose: STOPP/START is a physiological systems-based explicit set of criteria that attempts to define the clinically important prescribing problems relating to potentially inappropriate medications (PIMs-STOPP criteria) and potential prescribing omissions (PPOs-START criteria). The previous two versions of STOPP/START criteria were published in 2008 and 2015. The present study describes the revised and updated third version of the criteria.
Methods: A detailed system-by-system review of the published literature from April 2014 to March 2022 was undertaken with the aim of including clinically important new explicit PIM and PPO criteria and removing any criteria considered to be no longer correct or outdated. A panel of 11 academic physicians with recognized expertise in geriatric pharmacotherapy from 8 European countries participated in a Delphi panel with the task of validating the draft criteria. The panel was presented with the draft new criteria using the SurveyMonkey® on-line platform in which panelists were asked to indicate their level of agreement on a five-point Likert scale.
Results: Two hundred and four evidence-based draft criteria (one hundred and forty-five STOPP criteria, fifty-nine START criteria) were presented to panelists for assessment using the Delphi validation method. Over the course of four rounds of Delphi validation, the panel achieved consensus on 133 STOPP criteria and 57 START criteria, i.e., 190 STOPP/START criteria in total representing a 66.7% increase in the number of criteria compared to STOPP/START version 2 published in 2015.
Conclusion: A fully revised and updated version of STOPP/START criteria has been validated by a European expert panel using the Delphi consensus process.
Keywords: Adverse drug events; Medication review; Multimorbidity; Older people; Polypharmacy; STOPP/START criteria.
© 2023. The Author(s).
Conflict of interest statement
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Figures
Comment in
-
STOPP/START version 3: even better with age.Eur Geriatr Med. 2023 Aug;14(4):635-637. doi: 10.1007/s41999-023-00784-z. Eur Geriatr Med. 2023. PMID: 37256474 Free PMC article. No abstract available.
-
STOPP/START version 3: looks great, fits well, but itches.Eur Geriatr Med. 2023 Aug;14(4):639-641. doi: 10.1007/s41999-023-00828-4. Eur Geriatr Med. 2023. PMID: 37421573 No abstract available.
-
STOPP/START version 3: overhauled resources to support older people. What will we do next?Eur Geriatr Med. 2023 Aug;14(4):643-644. doi: 10.1007/s41999-023-00832-8. Eur Geriatr Med. 2023. PMID: 37477805 No abstract available.
-
Clinical appraisal of STOPP/START version 3 criteria.Eur Geriatr Med. 2023 Oct;14(5):1149-1150. doi: 10.1007/s41999-023-00839-1. Epub 2023 Jul 27. Eur Geriatr Med. 2023. PMID: 37498508 No abstract available.
-
Authors' response to points raised by Boland et al. regarding STOPP/START version 3 criteria.Eur Geriatr Med. 2023 Oct;14(5):1151-1154. doi: 10.1007/s41999-023-00875-x. Epub 2023 Oct 11. Eur Geriatr Med. 2023. PMID: 37819545 No abstract available.
References
-
- https://www.nice.org.uk/guidance/ng5 (accessed Sep 12, 2022)
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous